Merck KGaA, through its life science arm MilliporeSigma, is again increasing its manufacturing footprint for ADCs, this time by allocating €70 million ($75.6 million) to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.